Hemopericardium in a Sirolimus-Treated Renal Transplant Patient

被引：0
|
作者：
Groudan, Kevin [1 ]
Sawalha, Khalid [2 ]
Bhat, Anusha G. [1 ]
Eltanbedawi, Ahmed [1 ]
Ambesh, Paurush [3 ]
机构：
[1] Baystate Med Ctr, Internal Med, Springfield, MA 01199 USA
[2] Univ Massachusetts, Med Sch Baystate, Internal Med, Springfield, MA USA
[3] Univ Massachusetts, Med Sch Baystate, Cardiovasc Med, Springfield, MA USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2020年 / 12卷 / 08期
关键词：
hemopericardium; sirolimus; renal transplant; immunosuppression; LYMPHEDEMA;
D O I：
10.7759/cureus.9508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be reported in the literature. We report the first case of sirolimus-induced hemopericardium in a renal transplant patient.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Azathioprine/ciclosporinMALT lymphoma in a renal transplant recipient; remission with sirolimus: case report
    Reactions Weekly, 2009, 1266 (1) : 9 - 9
  • [42] Conversion to sirolimus in pediatric renal transplant patients: A single-center experience
    Monteverde, Marta L.
    Ibanez, Juan
    Balbarrey, Ziomara
    Chaparro, Alicia
    Diaz, Mario
    Turconi, Amalia
    PEDIATRIC TRANSPLANTATION, 2012, 16 (06) : 582 - 588
  • [43] Sirolimus Conversion May Suppress Viral Replication in Hepatitis C Virus-Positive Renal Transplant Candidates
    Soliman, Amin
    Fathy, Ahmed
    Khashab, Sahier
    Shaheen, Noha
    Soliman, Mahmoud
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (05) : 408 - 411
  • [44] Giant warts in a kidney transplant patient: regression with sirolimus
    Kostaki, M.
    Venetz, J. P.
    Nseir, G.
    Meylan, P.
    Sahli, R.
    Pascual, M.
    Laffitte, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (05) : 1148 - 1150
  • [45] Sirolimus and mirabegron interaction in a hematopoietic cell transplant patient
    Engle, Jeff A.
    Fair, Christina
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (08) : 627 - 631
  • [46] Addition of induction therapy offsets the hazard of marked calcineurin minimization among renal transplant recipients treated with sirolimus
    Kahan, B. D.
    Benavides, C.
    Schoenberg, L.
    Podbielski, J.
    Green, C.
    CLINICAL NEPHROLOGY, 2010, 73 (05) : 344 - 353
  • [47] Case of fulminant leptospirosis in a renal transplant patient
    Gerasymchuk, L.
    Swami, A.
    Carpenter, C. F.
    Samarapungavan, D.
    Batke, M.
    Kanhere, R.
    Robinson-Dunn, B.
    Wilson, J. D.
    Szela, J.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (05) : 454 - 457
  • [48] Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients
    Pescovitz, Mark D.
    Vincenti, Flavio
    Hart, Marquis
    Melton, Larry
    Whelchel, John
    Mulgaonkar, Shamkant
    McKay, Diane
    Leung, Mimi
    Calleja, Elizabeth
    Bouw, M. Rene
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (06) : 758 - 771
  • [49] Steady-State Pharmacokinetics of Sirolimus in Stable Adult Chinese Renal Transplant Patients
    Wang, Huifen Faye
    Qiu, Feng
    Wu, Xiongfe
    Fang, Juanzhi
    Crownover, Penelope
    Korth-Bradley, Joan
    Schulman, Seth
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (03): : 235 - 241
  • [50] Sirolimus-induced interstitial pneumonitis in a renal transplant recipient
    Kanaan, Nada
    Coche, Emmanuel
    Goffin, Eric
    CLINICAL KIDNEY JOURNAL, 2008, 1 (02): : 124 - 125
12345